
- /
- Supported exchanges
- / DU
- / CLH.DU
CARDINAL HEALTH - Dusseldorf Stock Exchang (CLH DU) stock market data APIs
CARDINAL HEALTH - Dusseldorf Stock Exchang Financial Data Overview
There is no Profile data available for CLH.DU.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get CARDINAL HEALTH - Dusseldorf Stock Exchang data using free add-ons & libraries
Get CARDINAL HEALTH - Dusseldorf Stock Exchang Fundamental Data
CARDINAL HEALTH - Dusseldorf Stock Exchang Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get CARDINAL HEALTH - Dusseldorf Stock Exchang Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get CARDINAL HEALTH - Dusseldorf Stock Exchang End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CARDINAL HEALTH - Dusseldorf Stock Exchang News
![[Latest] Global Aspirin Market Size/Share Worth USD 3.40 Billion by 2034 at a 3.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](/build/assets/fallback7-edDikJRC.jpg)
[Latest] Global Aspirin Market Size/Share Worth USD 3.40 Billion by 2034 at a 3.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Aspirin Market size & share revenue was value...


Cardinal Health Stock Gets Relative Strength Rating Lift
Cardinal Health shows improving price performance, earning an upgrade to its IBD Relative Strength Rating Continue Reading View Comments

Here's Why Cardinal Health (CAH) is a Strong Value Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Achieving those goals is made easier with the Zac...

How McKesson’s (MCK) Exclusive PHYRAGO Distribution Could Shape Its Specialty Pharma Growth Trajectory
Earlier this week, Cycle Pharmaceuticals announced the launch of PHYRAGO, a new oncology therapy for leukemia, developed with Handa Therapeutics and made exclusively available in the US through Onco36...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.